Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_assertion type Assertion NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_head.
- NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_assertion description "[Dose-dependent reduction in EGF-stimulated A549 motility was observed with the PD98059 MEK1 inhibitor and the batimastat (BB-94) inhibitor of MMP activity, but not with the SB203580 inhibitor of p38 kinase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_provenance.
- NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_assertion evidence source_evidence_literature NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_provenance.
- NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_assertion SIO_000772 11585739 NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_provenance.
- NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_assertion wasDerivedFrom befree-2016 NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_provenance.
- NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_assertion wasGeneratedBy ECO_0000203 NP331883.RACf83CIy4C2cu7PfY8ct4w_NZALVQcL0du6cS4Eu5dHc130_provenance.